How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study-Reference-Cited by-同舟云学术

How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study

Published:2017-03-06 Issue:3 Volume:12 Page:e0173338
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Quatremère Guillemette,Guiguet Marguerite,Girardi Patricia,Liaud Marie-Noëlle,Mey Coline,Benkhoucha Cynthia,Barbier Franck,Cattaneo Graciela,Simon Anne,Rojas Castro Daniela

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Age, time living with diagnosed HIV infection, and self-rated health;JA McGowan;HIV Med,2017

2. Antiretroviral Therapy (ART) Side Effect Impacted on Quality of Life, and Depressive Symptomatology: A Mixed-Method Study;W-T Chen;J AIDS Clin Res,2013

3. Factors that influence adherence to HIV medications: perceptions of women and health care providers;E Abel;J Assoc Nurses AIDS Care JANAC,2003

4. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis;I Al-Dakkak;AIDS Care,2013

5. Factors Supporting and Inhibiting Adherence to HIV Medication Regimen in Women: A Qualitative Analysis of Patient Interviews;O Fagbami;Open AIDS J,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Associated with Time to Initial Antiretroviral Therapy Discontinuation in the DC Cohort;AIDS Research and Human Retroviruses;2024-07-23

2. Investigating Daily Practices of Self-care to Inform the Design of Supportive Health Technologies for Living and Ageing Well with HIV;CHI Conference on Human Factors in Computing Systems;2022-04-29

3. Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1–Diagnosed Adults;Patient Preference and Adherence;2022-01

4. Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat;Biomedicines;2021-03-18